rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
9419
|
pubmed:dateCreated |
2004-5-3
|
pubmed:abstractText |
Adult bone-marrow-derived mesenchymal stem cells are immunosuppressive and prolong the rejection of mismatched skin grafts in animals. We transplanted haploidentical mesenchymal stem cells in a patient with severe treatment-resistant grade IV acute graft-versus-host disease of the gut and liver. Clinical response was striking. The patient is now well after 1 year. We postulate that mesenchymal stem cells have a potent immunosuppressive effect in vivo.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1474-547X
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:day |
1
|
pubmed:volume |
363
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1439-41
|
pubmed:dateRevised |
2008-9-9
|
pubmed:meshHeading |
pubmed-meshheading:15121408-Acute Disease,
pubmed-meshheading:15121408-Adult,
pubmed-meshheading:15121408-Child,
pubmed-meshheading:15121408-Chromosomes, Human, X,
pubmed-meshheading:15121408-Chromosomes, Human, Y,
pubmed-meshheading:15121408-Female,
pubmed-meshheading:15121408-Graft vs Host Disease,
pubmed-meshheading:15121408-Haploidy,
pubmed-meshheading:15121408-Humans,
pubmed-meshheading:15121408-Immunosuppression,
pubmed-meshheading:15121408-In Situ Hybridization, Fluorescence,
pubmed-meshheading:15121408-Intestinal Mucosa,
pubmed-meshheading:15121408-Lymphocyte Culture Test, Mixed,
pubmed-meshheading:15121408-Male,
pubmed-meshheading:15121408-Mesenchymal Stem Cell Transplantation,
pubmed-meshheading:15121408-Mesenchymal Stem Cells,
pubmed-meshheading:15121408-Transplantation, Homologous,
pubmed-meshheading:15121408-Transplantation Chimera
|
pubmed:year |
2004
|
pubmed:articleTitle |
Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells.
|
pubmed:affiliation |
Division of Clinical Immunology and Centre for Allogeneic Stem Cell Transplantation, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden. Katarina.Leblanc@medhs.ki.se
|
pubmed:publicationType |
Journal Article,
Case Reports,
Research Support, Non-U.S. Gov't
|